QUOTE AND NEWS
GenEng News  Aug 31  Comment 
Repligen, once a strongly focused therapeutics firm, has transformed itself into a bioprocess products company in only a few years’ time. As the company’s former COO Tony J. Hunt takes the helm as president and CEO after the May retirement of...
newratings.com  Aug 4  Comment 
WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc (LGND) on Tuesday reported second-quarter net earnings of $23.6 million or $1.11 per share compared with $1.6 million or $0.07 per share last year. Excluding items, adjusted earnings for the...
Benzinga  Jul 29  Comment 
In a report rolled out Wednesday, Roth Capital analysts Joseph Pantginis and Assaf Vestin reiterated a Buy rating and $135.00 price target on shares of Ligand Pharmaceuticals Inc. (NASDAQ: LGND), after partner Viking Therapeutics Inc (NASDAQ:...
newratings.com  Jul 24  Comment 
WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND) announces the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency (EMA) adopted a positive opinion for Revolade (eltrombopag), a Novartis product, for...
GenEng News  Jul 14  Comment 
A new study at the University of Wisconsin-Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials. One therapy is a vaccine that targets a structure on the outside of cancer cells, while the...





You may also be interested in articles related to Ligand Pharmaceuticals (LGND):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki